Projects per year
Fingerprint The Fingerprint is created by mining the titles and abstracts of the person's research outputs and projects/funding awards to create an index of weighted terms from discipline-specific thesauri.
- 7 Similar Profiles
Idiopathic Pulmonary Fibrosis
Medicine & Life Sciences
Interstitial Lung Diseases
Medicine & Life Sciences
Lung
Medicine & Life Sciences
Alveolar Epithelial Cells
Medicine & Life Sciences
Fibronectins
Medicine & Life Sciences
Fibrinogen
Medicine & Life Sciences
Integrins
Medicine & Life Sciences
Sarcoidosis
Medicine & Life Sciences
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Projects 2008 2021
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, Tolerability, Biological Activity, and PK of ND L02 s0201 in Subjects with Idiopathic Pulmonary Fibrosis (IPF)
10/2/18 → 1/1/21
Project: Research project
Idiopathic Pulmonary Fibrosis
Placebos
Safety
Randomized, Double-blind, Parallel-group, Placebo-controlled, 52-week, Phase IIb Study to AssessEfficacy and Safety of GLPG1690 on Top of Pirfenidone or Nintedanib in Patients with IdiopathicPulmonary Fibrosis (IPF)
9/19/18 → 9/18/21
Project: Research project
Idiopathic Pulmonary Fibrosis
Fibrosis
Placebos
Safety
pirfenidone
Systemic Scleroderma
Interstitial Lung Diseases
Safety
nintedanib
Pulmonary Fibrosis
Registries
Medical Education
Research Output 1995 2019
Acute exacerbation of interstitial lung disease after procedures
Amundson, W. H., Racila, E. V., Allen, T. L., Dincer, H. E., Tomic, R., Bhargava, M., Perlman, D. M. & Kim, H. J., Apr 1 2019, In : Respiratory Medicine. 150, p. 30-37 8 p.Research output: Contribution to journal › Review article
Interstitial Lung Diseases
Idiopathic Pulmonary Fibrosis
Decision Making
Fibrosis
Inflammation
Nintedanib for Systemic Sclerosis-Associated Interstitial Lung Disease
SENSCIS Trial Investigators & Kim, H. J., Jun 27 2019, In : The New England journal of medicine. 380, 26, p. 2518-2528 11 p.Research output: Contribution to journal › Article
Systemic Scleroderma
Interstitial Lung Diseases
Placebos
Vital Capacity
Confidence Intervals
Patient Registries in Idiopathic Pulmonary Fibrosis
Culver, D. A., Behr, J., Belperio, J. A., Corte, T. J., de Andrade, J. A., Flaherty, K. R., Gulati, M., Huie, T. J., Lancaster, L. H., Roman, J., Ryerson, C. J. & Kim, H. J., Jul 15 2019, In : American journal of respiratory and critical care medicine. 200, 2, p. 160-167 8 p.Research output: Contribution to journal › Article
Idiopathic Pulmonary Fibrosis
Registries
Precision Medicine
Rare Diseases
Disease Progression
Predictors of death or lung transplant after a diagnosis of idiopathic pulmonary fibrosis: insights from the IPF-PRO Registry
IPF-PRO™ Registry investigators, May 30 2019, In : Respiratory research. 20, 1, p. 105Research output: Contribution to journal › Article
Idiopathic Pulmonary Fibrosis
Registries
Transplants
Lung
Vital Capacity
Does normal spirometry rule out an obstructive or restrictive ventilatory defect?
Fortis, S., Corazalla, E. O. & Kim, H. J., Jan 1 2017, In : Respiratory Investigation. 55, 1, p. 55-57 3 p.Research output: Contribution to journal › Article
Respiration Disorders
Lung Volume Measurements
Obstructive Lung Diseases
Spirometry
Smoking